Natalia Neparidze

Hematology
35 Park St
New Haven, CT 06519

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease.

Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease.

Journal: American journal of hematology
Published: May 27, 2026

Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma.

Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma.

Journal: JCO oncology practice
Published: May 04, 2026

Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).

Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).

Journal: European journal of haematology
Published: April 29, 2026

Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.

Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.

Journal: Clinical lymphoma, myeloma & leukemia
Published: April 21, 2026

Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community Network.

Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community Network.

Journal: Cancers
Published: April 03, 2026

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Journal: Haematologica
Published: February 05, 2026

Efficacy of Interventions for Newly Diagnosed Multiple Myeloma: An Umbrella Review.

Efficacy of Interventions for Newly Diagnosed Multiple Myeloma: An Umbrella Review.

Journal: Journal of clinical & experimental oncology
Published: January 28, 2026

Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Journal: Leukemia & lymphoma
Published: October 29, 2025

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding.

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding.

Journal: Research and practice in thrombosis and haemostasis
Published: October 16, 2025

Smoldering multiple myeloma in the United States: a population-based analysis.

Smoldering multiple myeloma in the United States: a population-based analysis.

Journal: Blood advances
Published: July 18, 2025

Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012-2022.

Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012-2022.

Journal: American journal of hematology
Published: July 07, 2025

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib.

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib.

Journal: Blood neoplasia
Published: May 28, 2025
Showing 1-12 of 51

Last Updated: 09/26/2026